
|Videos|November 8, 2011
Dr. Diehl on the Unique Nature of Hodgkin's Lymphoma
Author(s)Volker Diehl, MD
Dr. Volker Diehl from the University of Cologne, Germany on the Unique Nature of Hodgkin's Lymphoma
Advertisement
Volker Diehl, MD, Professor of Medicine, Emeritus, University of Cologne, Germany, explains that Hodgkin's lymphoma is unique because the microenvironment contains a minority of tumors cells and an abundance of reactive cells.
This disease demonstrates an intelligent interaction between the microenvironment and the tumor cells. When treating Hodgkin's lymphoma is it necessary to kill all cells including the inert tumor cells and the not yet well-defined clonogenic cells that interact with the microenvironment.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5




































